Department of Thoracic Surgery, Sant'Andrea Hospital, Sapienza University of Rome, Via di Grottarossa, 1035, Rome 00189, Italy.
Thorac Surg Clin. 2013 Aug;23(3):337-47. doi: 10.1016/j.thorsurg.2013.05.007.
Sleeve lobectomy (SL) (lobectomy associated with resection and reconstruction of the bronchus, the pulmonary artery, or both) has proved to be a suitable choice for the treatment of centrally sited non-small cell lung cancer. SL for lung cancer is indicated when a tumor or an N1 lymph node infiltrates the origin of a lobar bronchus, the origin of the lobar branches of the pulmonary artery, or both but not to the extent that a pneumonectomy is required. SL can be performed safely and effectively, even after induction therapy, without an increased complication rate.
袖状肺叶切除术(SL)(肺叶切除术联合支气管、肺动脉或两者的切除和重建)已被证明是治疗中央型非小细胞肺癌的一种合适选择。当肿瘤或 N1 淋巴结侵犯肺叶支气管、肺叶动脉分支的起源或两者时,但不需要进行全肺切除术时,可选择进行肺癌的 SL。即使在诱导治疗后,SL 也可以安全有效地进行,而不会增加并发症的发生率。